Longwood Fund

Longwood Fund Longwood Fund manages $650M+ in total AUM, with Fund VI closing at $180M as their largest fund to date. The track record is exceptional for biotech company creation: partners have co-founded approximately 25 companies with 20+ launched and marketed drugs and therapies. Portfolio companies include GRAIL, BridgeBio, and PTC Therapeutics, alongside clinical-stage assets, with 10 IPOs and 8 acquisitions across the portfolio. The company founding pedigree tells the real story. Longwood